+44 20 3868 9735
BioNumerik Pharmaceuticals, Inc.8122 Data Point Dr., Suite 1250, San Antonio, TX 78229, USA
Ayala PY is currently working as research scholar in BioNumerik Pharmaceuticals, Inc. in San Antonio, USA. His research interest includes Wide range of publications like Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787. His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals.
His research interest incudes the relevance of Tavocept; adenocarcinoma; chemo-enhancing; crizotinib; non-small-cell lung cancer.